Rehmann Capital Advisory Group Acquires New Position in Mylan


Rehmann Capital Advisory Group acquired a new position in Mylan in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 5,571 shares of the company's stock, valued at approximately $236,000.



from Biotech News